IDXX

#328
Idexx Laboratories Inc
584.05 USD
+1.75%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
584.05
584.05
Годовой диапазон
398.75
769.98
Дневное изменение
+1.75%
Месячное изменение
+0.25%
6-месячное изменение
-8.77%
Годовое изменение
+44.10%
Предыдущее закрытие
574.00
Открыть
584.05
Bid
Ask
Минимум
584.05
High
584.05
Объем
166
Открыть полный график

Financials

Обзор Отчетность Статистика
Квартал Год
  • Market Capitalization 46.5 B
  • Employee 11 K
  • Founded 1983
  • CEO Jay Mazelsky
  • Website www.idexx.com
  • Headquarter Delaware, United States
  • FIGI BBG000BLRT07
  • Industry Technology
Общий доход
Чистая прибыль
Базовая прибыль на акцию
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты
Коэффициент цена/прибыль
51.72
Коэффициент цена/денежный поток
12.76

IDEXX Laboratories Inc

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses. In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.

Новости